Effects of PTX1 expression on growth and tumorigenicity of the prostate cancer cell line PC-3

DNA and Cell Biology

Volumn 22, Issue 7, 2003, Pages 469-474

  Liu, Xianhong ^a   Daskal, Ierachmiel ^a   Kwok, Simon C M ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; BETA GALACTOSIDASE; COMPLEMENTARY DNA; GENE PRODUCT; PROTEIN; PROTEIN PTX1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN PC 3; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PTX1 GENE;

ANIMALS; CELL AGING; CELL DIVISION; DNA, ANTISENSE; DNA, COMPLEMENTARY; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE; MICE, NUDE; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; MUS MUSCULUS;

EID: 0042028377     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454903322247343     Document Type: Article

References (14)

1. ALBINI, A., IWAMOTO, Y., KLEINMAN, H.K., MARTIN, G.R., AARONSON, S.A., KOZLOWSKI, J.M., and MCEWAN, R.N. (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47, 3239-3245.
2. BRINGOLD, F., and SERRANO, M. (2000). Tumor suppressors and oncogenes in cellular senescence. Exp. Gerontol. 35, 317-329.
3. CAMPISI, J. (2000). Cancer, aging and cellular senescence. In Vivo 14, 183-188.
4. CAMPISI, J. (2001). Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11, S27-31.
5. DIMRI, G.P., LEE, X., BASILE, G., ACOSTA, M., SCOTT, G., ROSKELLEY, C., MEDRANO, E.E., LINSKENS, M., RUBELJ, I., PEREIRA-SMITH, O., et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92, 9363-9367.
6. GOSSEN, M., and BUJARD, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547-5551.
7. GOSSEN, M., and BUJARD, H. (1995). Efficacy of tetracycline-controlled gene expression is influenced by cell type: Commentary. BioTechniques 19, 213-216.
8. GSCHWEND, J.E., FAIR, W.R., and POWELL, C.T. (1997). Evaluation of the tetracycline-repressible transactivator system for inducible gene expression in human prostate cancer cell lines. Prostate 33, 166-176.
9. GU, M., MENG, K., and MAJERUS, P.W. (1996). The effect of over-expression of the protein tyrosine phosphatase PTPMEG on cell growth and on colony formation in soft agar in COS-7 cells. Proc. Natl. Acad. Sci. USA 93, 12980-12985.
10. JARRARD, D.F., BOVA, G.S., EWING, C.M., PIN, S.S., NGUYEN, S.H., BAYLIN, S.B., CAIRNS, P., SIDRANSKY, D., HERMAN, J.G., and ISAACS, W.B. (1997). Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer. Genes Chromosomes Cancer 19, 90-96.
11. KWOK, S.C.M., LIU, X., and DASKAL, I. (2001). Molecular cloning, expression, localization, and gene organization of PTX1, a human nuclear protein that is downregulated in prostate cancer. DNA Cell Biol. 20, 349-357.
12. LUNDBERG, A.S., HAHN, W.C., GUPTA, P., and WEINBERG, R.A. (2000). Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12, 705-709.
13. RUBIN, S.J., HALLAHAN, D.E., ASHMAN, C.R., BRACHMAN, D.G., BECKET, M.A., VIRUDACHALAM, S., YANDELL, D.W., and WEICHSELBAUM, R.R. (1991). Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes. J. Surg. Oncol. 46, 31-36.
14. WANG, Y., O'MALLEY, B.W., JR., TSAI, S.Y., and O'MALLEY, B.W. (1994). A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA 91, 8180-8184.